Forum for Science, Industry and Business

No compulsory genetic testing for newborn babies in Europe

European Research Commissioner Philippe Busquin today rejected stories in several media claiming he had called for genetic testing of all newborn babies in Europe. Mr Busquin said: “I have never advocated any such point of view. It is not the role nor the intention of the Commission to ask EU Member States to impose universal genetic screening of babies. Genetic testing is a matter of free choice and of ethical rules being decided by EU Member States. The Commission does not regulate ethics. I certainly welcome the contribution of the expert group on genetic testing which presented its report to the Commission on May 6-7, 2004. But its recommendations are simple suggestions – and they don’t call for universal genetic testing of babies! Genetic testing can certainly help in the early detection of illnesses, but can never be made compulsory. European citizens rightly expect that the results of genetic tests are reliable and that their genetic information is used properly and following strict quality and ethical standards. The Commission is in particularly studying the issue of quality and reliability of this new technology, that must be used in a responsible and voluntary way and in a climate of confidence with the public at large.”

Independent advice

On December 2002, the European Commission established an expert group to address the ethical, legal and social implications of genetic testing. The Group included representatives from NGOs (including patient organisations), pharmaceutical companies (GSK, Roche, Novartis, Bayer, Genzyme), scientists and representatives from academia specialising in law, philosophy, ethics and medicine. The Group was acting in full autonomy and independence. It prepared a report and 25 recommendations on the ethical, legal and social implications of genetic testing. They only reflect the views of the expert group’s members and are not legally binding.

Fabio Fabbi | EU Commission
Further information:
http://europa.eu.int
http://europa.eu.int/comm/research/conferences/2004/genetic/index_en.htm

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...